Objective to study the interaction of renin-angiotensin system (RAS) and atrial natriuretic factor (ANF) under acute angiotensin converting enzyme inhibitors (ACEI) in chronic renal failure (CRF).
目的了解慢性肾衰(CRF)患者应用转换酶抑制剂(acei)后血浆心钠素(ANF)和肾素-血管紧张素系统(RAS)激素的相互影响。
Objective: This study was to evaluate the clinical effects of angiotensin converting enzyme inhibitors (ACEI) with aspirin treatment for acute myocardial infarction (AMI).
目的：研究阿司匹林和血管紧张素转换酶抑制剂(acei)联合使用对急性心肌梗塞(ami)患者病死率的影响。
OBJECTIVE:To summarize the aspect of clinical usage and research progress in angiotensin converting enzyme inhibitors(ACEI)and evaluate its clinical efficacy and safety.
目的：阐述血管紧张素转换酶抑制剂的研究进展和临床应用的历程，评价其疗效与安全性。
Its mechanism was realized not by the angiotensin-converting enzyme inhibitors (ACEI) effect, but by inhibition on the expression of AT1R.
其调控机制不是通过其血管紧张素转换酶抑制剂(acei)效应，而是通过抑制AT1R的表达来实现的。
The actual utilization rate of beta blockers(BB)and angiotensin-converting enzyme inhibitors(ACEI)was 49.4 and 65.4, respectively.
受体阻滞剂（BB）和血管紧张素转换酶抑制剂（ACEI）的实际使用率分别为49·4%、65·4%。
The actual utilization rate of beta blockers(BB)and angiotensin-converting enzyme inhibitors(ACEI)was 49.4 and 65.4, respectively.
受体阻滞剂（BB）和血管紧张素转换酶抑制剂（ACEI）的实际使用率分别为49·4%、65·4%。
应用推荐